US › Healthcare

Icecure Medical (ICCM)

US · Healthcare · Medical Devices

$1.06+1.92%

Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue

$907,000

Revenue YoY

+72.8%

Net profit

$-4.5M

EPS

$-3.11

EPS estimate

$-1.37

Net margin

-496.3%

EPS came in at -3.11 against a street estimate of -1.37 — a miss of 127.0%.

Key statistics

Market cap

$4.8M

Forward P/E

0.0

P/B

0.71

Book value

$3.47

EPS (TTM)

$-6.84

52-week high

$25.79

52-week low

$0.96

50-day MA

$2.13

200-day MA

$9.05

Beta

0.43

Analyst view

Analysts rate Icecure Medical a strong buy (3 buy, 0 hold, 0 sell out of 3) with an average price target of $22.67.

Shareholding

Insiders

51.49%

Institutions

12.60%

Largest institutional holders

Fund	Stake
Jane Street Group LLC	0.75%
Scientech Research LLC	0.70%
Gunderson Capital Management Inc	0.43%
UBS Group AG	0.37%
HRT FINANCIAL LLC	0.33%
JPMorgan Chase & Co	0.13%
Morgan Stanley - Brokerage Accounts	0.09%
SBI Securities Co Ltd	0.01%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Icecure Medical — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-10-19.